As a stable and reliable inflammatory marker, CRP has been shown to upregulate the expression of adhesion molecules and monocyte chemokines, inhibit the production of endothelial nitric oxide synthase (eNOS), and promote arterial thrombosis, indicating direct involvement in the occurrence of atherosclerosis [44–46]. The gene discussed is NOS3; the disease is atherosclerosis.